NVTA vs. ACON, CNTG, LH, DGX, NTRA, EXAS, RDNT, GH, FTRE, and VCYT
Should you be buying Invitae stock or one of its competitors? The main competitors of Invitae include Aclarion (ACON), Centogene (CNTG), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Natera (NTRA), Exact Sciences (EXAS), RadNet (RDNT), Guardant Health (GH), Fortrea (FTRE), and Veracyte (VCYT). These companies are all part of the "medical laboratories" industry.
Aclarion (NASDAQ:ACON) and Invitae (NYSE:NVTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.
Aclarion has higher earnings, but lower revenue than Invitae.
Aclarion has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Invitae has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500.
Invitae has a consensus price target of $1.00, suggesting a potential upside of 124,900.00%. Given Aclarion's higher possible upside, analysts clearly believe Invitae is more favorable than Aclarion.
Invitae received 450 more outperform votes than Aclarion when rated by MarketBeat users. However, 100.00% of users gave Aclarion an outperform vote while only 60.62% of users gave Invitae an outperform vote.
7.5% of Aclarion shares are held by institutional investors. Comparatively, 61.3% of Invitae shares are held by institutional investors. 22.3% of Aclarion shares are held by insiders. Comparatively, 0.7% of Invitae shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Aclarion had 2 more articles in the media than Invitae. MarketBeat recorded 3 mentions for Aclarion and 1 mentions for Invitae. Invitae's average media sentiment score of 1.15 beat Aclarion's score of 0.00 indicating that Aclarion is being referred to more favorably in the media.
Invitae has a net margin of -299.14% compared to Invitae's net margin of -10,246.33%. Invitae's return on equity of -2,554.98% beat Aclarion's return on equity.
Summary
Aclarion and Invitae tied by winning 7 of the 14 factors compared between the two stocks.
Get Invitae News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
